Aphria offers 90% upside, but this return won’t come for freeRead More»
Internationally renowned for his salient predictions of market bubbles, Chris provides global investment insights in his weekly column 'Macro Battleship'.
The most hyped IPO of the year is finally here. Helping you decide if Coinbase is priced for perfection or a screaming buy.Read More»
As we feared and warned investors about earlier, the company has announced today that it is doing a at-the-market equity raise program valued at $49M.Read More»
A commodity supercycle is approaching. Learn why Copper will be the king of the commodities.Read More»
AMC is going bankrupt, unless the WallStreetBets crew can save it. But will they?Read More»
Grizzle outlines the structural share price upside of Compass Pathways and its psilocybin drug: COMP 360 to treat depression.Read More»
Grizzle sits down with Terry Chong (Partner, Grizzle Venture) to discuss one of the most anticipated psychedelic IPOs: Compass PathawaysRead More»